Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
02:36:22 EDT Mon 29 Apr 2024
Enter Symbol
or Name
USA
CA



News for U:EPIX from 2023-04-30 to 2024-04-29 - 36 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-09 08:00U:EPIXNews ReleaseESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
2024-04-09 08:00U:EPIXNews ReleaseESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
2024-03-07 20:13U:EPIXNews ReleaseESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
2024-03-07 20:13U:EPIXNews ReleaseESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
2024-02-13 07:00U:EPIXNews ReleaseESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023
2024-02-13 07:00U:EPIXNews ReleaseESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023
2024-02-06 08:00U:EPIXNews ReleaseESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
2024-02-06 08:00U:EPIXNews ReleaseESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
2024-01-25 10:00U:EPIXNews ReleaseESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium
2024-01-25 10:00U:EPIXNews ReleaseESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium
2023-12-12 07:00U:EPIXNews ReleaseESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2023
2023-12-12 07:00U:EPIXNews ReleaseESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2023
2023-11-21 08:00U:EPIXNews ReleaseESSA Pharma to Present at the Piper Sandler 35th Annual Healthcare Conference
2023-11-21 08:00U:EPIXNews ReleaseESSA Pharma to Present at the Piper Sandler 35th Annual Healthcare Conference
2023-11-08 08:00U:EPIXNews ReleaseESSA Pharma to Present at the Jefferies London Healthcare Conference
2023-11-08 08:00U:EPIXNews ReleaseESSA Pharma to Present at the Jefferies London Healthcare Conference
2023-11-06 17:51U:EPIXNews ReleaseESSA Pharma Enters into At-The-Market Equity Offering Sales Agreement
2023-11-06 17:51U:EPIXNews ReleaseESSA Pharma Enters into At-The-Market Equity Offering Sales Agreement
2023-10-26 17:41U:EPIXNews ReleaseESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 30th Annual Prostate Cancer Foundation Scientific Retreat
2023-10-26 17:41U:EPIXNews ReleaseESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 30th Annual Prostate Cancer Foundation Scientific Retreat
2023-10-21 09:00U:EPIXNews ReleaseESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the European Society of Medical Oncology 2023 Congress
2023-10-21 09:00U:EPIXNews ReleaseESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the European Society of Medical Oncology 2023 Congress
2023-09-18 07:00U:EPIXNews ReleaseESSA Pharma Announces Initiation of Phase 2 Study Evaluating Masofaniten (EPI-7386) in Combination with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer
2023-09-18 07:00U:EPIXNews ReleaseESSA Pharma Announces Initiation of Phase 2 Study Evaluating Masofaniten (EPI-7386) in Combination with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer
2023-08-31 07:00U:EPIXNews ReleaseESSA Pharma Insiders Establish Automatic Securities Disposition Plans
2023-08-31 07:00U:EPIXNews ReleaseESSA Pharma Insiders Establish Automatic Securities Disposition Plans
2023-08-08 07:00U:EPIXNews ReleaseESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2023
2023-08-08 07:00U:EPIXNews ReleaseESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2023
2023-06-06 07:00U:EPIXNews ReleaseESSA Pharma Appoints Lauren Merendino to its Board of Directors
2023-06-06 07:00U:EPIXNews ReleaseESSA Pharma Appoints Lauren Merendino to its Board of Directors
2023-06-01 07:00U:EPIXNews ReleaseESSA Pharma to Present at 2023 Jefferies Healthcare Conference
2023-06-01 07:00U:EPIXNews ReleaseESSA Pharma to Present at 2023 Jefferies Healthcare Conference
2023-05-11 07:00U:EPIXNews ReleaseESSA Pharma to Present at JMP Securities Life Sciences Conference
2023-05-11 07:00U:EPIXNews ReleaseESSA Pharma to Present at JMP Securities Life Sciences Conference
2023-05-09 07:00U:EPIXNews ReleaseESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2023
2023-05-09 07:00U:EPIXNews ReleaseESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2023